Ravindran Ankathil

Ravindran Ankathil

Auto-generated profile, based on publicly available information

Ravindran Ankathil

Human Genome Centre, School of Medical Sciences, Universiti Sains Malaysia, Kubang Kerian, Kelantan, Malaysia

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 October 2007 in Journal of Cancer Research and Clinical Oncology
Verified
Journal Article
Closed access
PDF file
LSLeelakumari Sreeja
Leelakumari Sreeja
VSVolga S. Syamala
Volga S. Syamala
VSVani Syamala
Vani Syamala
SHSreedharan Hariharan
Sreedharan Hariharan
PRPraveenkumar B. Raveendran
Praveenkumar B. Raveendran
RARavindran Ankathil
Ravindran Ankathil

1 April 2014 in Leukemia Research
Verified
Journal Article
Closed access
MEMarjanu Hikmah Elias
Marjanu Hikmah Elias
ABAbdul Aziz Baba
Abdul Aziz Baba
AHAzlan Husin
Azlan Husin
RHRosline Hassan
Rosline Hassan
GSGoh Ai Sim
Goh Ai Sim
RARavindran Ankathil
Ravindran Ankathil

1 April 2014 in Biomedicine & Pharmacotherapy
Verified
Journal Article
Closed access
AAAnthony Au
Anthony Au
ABAbdul Aziz Baba
Abdul Aziz Baba
AGAi Sim Goh
Ai Sim Goh
SFS. Abdul Wahid Fadilah
S. Abdul Wahid Fadilah
ATAlan Teh
Alan Teh
RARavindran Ankathil
Ravindran Ankathil


29 March 2018 in Bioscience Reports
Verified
Journal Article
Open access
PDF file
STShing Cheng Tan
Shing Cheng Tan
MIMohd Pazudin Ismail
Mohd Pazudin Ismail
DDDaniel Roza Duski
Daniel Roza Duski
NONor Hayati Othman
Nor Hayati Othman
RARavindran Ankathil
Ravindran Ankathil
Information on the prevalence and type distribution of human papillomavirus (HPV) among Malaysian women is currently limited. The present study therefore aimed to provide an updated estimate on the prevalence and type distribution of HPV among Malaysian women with and without cervical cancer. Total DNA was isolated from the cervical cell specimens of 185 histopathologically confirmed cervical cancer patients and 209 cancer-free healthy females who were tested negative in a recent Pap test. Viral-specific DNA was subsequently amplified with biotinylated primers and hybridized to HPV type-specific probes via a proprietary “flow-through hybridization” process for determination of HPV genotype. It was demonstrated that 83.2% of the cervical cancer patients and none (0.0%) of the cancer-free females were positive for HPV infection. Among HPV-positive subjects, 14 different viral genotypes were observed, namely HPV16, 18, 31, 33, 35, 45, 52, 53, 58, 66/68, 73, 81, 82, and 84/26. A total of 91.6% of the HPV-positive subjects had single-type HPV infections and the remaining 8.4% were simultaneously infected by two HPV genotypes. The most common HPV infections found were HPV16 (35.7%), HPV18 (26.0%), HPV58 (9.1%), and HPV33 (7.1%) single-type infections, followed by HPV16 + HPV18 co-infections (5.2%). The study has successfully provided an updated estimate on the prevalence and type distribution of HPV among Malaysian women with and without cervical cancer. These findings could contribute valuable information for appraisal of the impact and cost-effectiveness of prophylactic HPV vaccines in the Malaysian population.

31 August 2013 in Medical Oncology
Verified
Journal Article
Closed access
PDF file
STShing Cheng Tan
Shing Cheng Tan
MSMohd Shafi’i Mohd Suzairi
Mohd Shafi’i Mohd Suzairi
AAAbdul Aziz Ahmad Aizat
Abdul Aziz Ahmad Aizat
MAMustapha Mohd Aminudin
Mustapha Mohd Aminudin
MNMohd Shahpudin Siti Nurfatimah
Mohd Shahpudin Siti Nurfatimah
RARavindran Ankathil
Ravindran Ankathil